[Double-blind trial treatment of anxiety with b 5833].
D000293:Adolescent; D000328:Adult; D000368:Aged; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D000987:Antisocial Personality Disorder / Q000188:drug therapy; D001007:Anxiety; D001008:Anxiety Disorders / Q000188:drug therapy; D001569:Benzodiazepines; D002986:Clinical Trials as Topic; D003291:Conversion Disorder / Q000188:drug therapy; D003863:Depression / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy; D010698:Phobic Disorders / Q000188:drug therapy; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D011602:Psychophysiologic Disorders / Q000188:drug therapy
D014151:Anti-Anxiety Agents; D010919:Placebos; D001569:Benzodiazepines
Essai de traitement de l'anxiété en double aveugle par le B5833